202 related articles for article (PubMed ID: 33452750)
1. Natural ghrelin in advanced cancer patients with cachexia, a case series.
Blum D; de Wolf-Linder S; Oberholzer R; Brändle M; Hundsberger T; Strasser F
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):506-516. PubMed ID: 33452750
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.
Garcia JM; Friend J; Allen S
Support Care Cancer; 2013 Jan; 21(1):129-37. PubMed ID: 22699302
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study.
Strasser F; Lutz TA; Maeder MT; Thuerlimann B; Bueche D; Tschöp M; Kaufmann K; Holst B; Brändle M; von Moos R; Demmer R; Cerny T
Br J Cancer; 2008 Jan; 98(2):300-8. PubMed ID: 18182992
[TBL] [Abstract][Full Text] [Related]
4. [The Treatment of Cancer Cachexia].
Tanaka S; Takayama K
Gan To Kagaku Ryoho; 2021 Aug; 48(8):987-991. PubMed ID: 34404062
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia/cachexia.
Chasen M; Hirschman SZ; Bhargava R
J Am Med Dir Assoc; 2011 Jan; 12(1):62-7. PubMed ID: 21194662
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
Naito T; Uchino J; Kojima T; Matano Y; Minato K; Tanaka K; Mizukami T; Atagi S; Higashiguchi T; Muro K; Takayama K; Furuse J; Morishima E; Takiguchi T; Tamura K
Cancer; 2022 May; 128(10):2025-2035. PubMed ID: 35195274
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin for the management of cachexia associated with cancer.
Khatib MN; Shankar AH; Kirubakaran R; Gaidhane A; Gaidhane S; Simkhada P; Quazi Syed Z
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012229. PubMed ID: 29489032
[TBL] [Abstract][Full Text] [Related]
8. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
Currow D; Temel JS; Abernethy A; Milanowski J; Friend J; Fearon KC
Ann Oncol; 2017 Aug; 28(8):1949-1956. PubMed ID: 28472437
[TBL] [Abstract][Full Text] [Related]
9. Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment.
Ali S; Chen JA; Garcia JM
Curr Opin Support Palliat Care; 2013 Dec; 7(4):368-75. PubMed ID: 24145681
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect.
Akamizu T; Kangawa K
Peptides; 2011 Nov; 32(11):2295-300. PubMed ID: 21635929
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease.
Cheung WW; Mak RH
Kidney Int; 2009 Jul; 76(2):135-7. PubMed ID: 19564855
[TBL] [Abstract][Full Text] [Related]
12. Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia.
Herodes M; Anderson LJ; Shober S; Schur EA; Graf SA; Ammer N; Salas R; Marcelli M; Garcia JM
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):835-846. PubMed ID: 36860137
[TBL] [Abstract][Full Text] [Related]
13. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Zhang H; Garcia JM
Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
[TBL] [Abstract][Full Text] [Related]
14. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
[TBL] [Abstract][Full Text] [Related]
15. Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.
Yoshimura M; Shiomi Y; Ohira Y; Takei M; Tanaka T
Eur J Pharmacol; 2017 Sep; 811():30-37. PubMed ID: 28529141
[TBL] [Abstract][Full Text] [Related]
16. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
[TBL] [Abstract][Full Text] [Related]
18. Gut hormones and the treatment of disease cachexia.
Ashby D; Choi P; Bloom S
Proc Nutr Soc; 2008 Aug; 67(3):263-9. PubMed ID: 18452642
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice.
Tsubouchi H; Yanagi S; Miura A; Matsumoto N; Kangawa K; Nakazato M
Eur J Pharmacol; 2014 Nov; 743():1-10. PubMed ID: 25257464
[TBL] [Abstract][Full Text] [Related]
20. Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.
Tsubouchi H; Yanagi S; Miura A; Mogami S; Yamada C; Iizuka S; Hattori T; Nakazato M
Nutr Res; 2014 Oct; 34(10):876-85. PubMed ID: 25270999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
